Divi's Laboratories Ltd.
NSE: DIVISLAB | BSE: 532488
₹6,710.50
₹8.00
(0.12%)
As on 08-May-2026IST
Market cap
₹1,78,100 Cr
Revenue (TTM)
₹10,314 Cr
P/E Ratio
71.8
P/B Ratio
11.1
Div. Yield
0.4 %
Quality Score
8/10
Growth Score
7/10
Valuation Score
3/10
Momentum Score
5/10
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
₹2,479 Cr
-
ROE
15.4 %
-
ROCE
20.5 %
-
Industry P/E
35.31
-
EV/EBITDA
45.7
-
Debt to Equity
0
-
Book Value
₹602.6
-
EPS
₹95.5
-
Face value
2
-
Shares outstanding
265,468,580
10 Years Aggregate
CFO
₹14,366.06 Cr
EBITDA
₹22,110.62 Cr
Net Profit
₹16,352.23 Cr
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Divi's Lab
| 5.0 | 14.7 | 11.4 | 9.1 | 26.8 | 10.7 | 20.7 |
|
BSE Sensex
| -8.7 | 3.6 | -7.5 | -4.2 | 8.2 | 9.5 | 11.9 |
|
BSE Healthcare
| 7.1 | 11.7 | 10.9 | 10.9 | 26.2 | 14.1 | 11.7 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|---|
|
Divi's Lab
| 5.3 | 55.7 | 14.4 | -27.0 | 21.5 | 111.2 | 25.1 |
|
BSE Sensex
| 9.1 | 8.1 | 18.7 | 4.4 | 22.0 | 15.8 | 14.4 |
|
BSE Healthcare
| -3.3 | 43.1 | 37.0 | -12.1 | 20.9 | 61.4 | -3.5 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Divi's Lab
|
6,710.5 | 1,78,100.2 | 10,314.0 | 2,479.0 | 28.5 | 16.7 | 71.8 | 11.1 |
| 1,121.3 | 13,757.5 | 2,512.3 | 543.7 | 28.3 | 19.3 | 25.3 | 4.3 | |
| 490.5 | 8,518.0 | 1,053.1 | 293.6 | 32.3 | 24.6 | 29 | 6.6 | |
| 1,173.9 | 12,294.0 | 1,158.7 | 309.6 | 31.9 | 17.3 | 39.3 | 6.5 | |
| 1,643.0 | 31,123.0 | 9,203.5 | 941.3 | 15.4 | 19.6 | 33.7 | 6.3 | |
| 398.5 | 4,341.7 | 159.3 | 47.8 | 39.0 | 18.6 | 90.9 | 15.7 | |
| 17,666.0 | 22,700.8 | 1,575.1 | 179.1 | 14.9 | 11.4 | 126.7 | 13.7 | |
| 2,463.1 | 4,066.9 | 707.5 | 115.2 | 17.8 | 19.4 | 35.3 | -- | |
| 965.6 | 4,451.3 | 588.5 | 102.9 | 22.1 | 12.7 | 43.8 | 5.3 | |
| 223.0 | 5,911.3 | 7.1 | -274.7 | -4,008.3 | -140.4 | -- | 8.9 |
Shareholding Pattern
View DetailsNews & Analysis
All News
3 min read•By Udhayaprakash
6 min read•By Kumar Shankar Roy
Premium pharma player: Divis Labs
1 min read•By Yash Rohra
How to spot current performers
2 min read•By Mohammed Ekramul Haque
2 min read•By Mohammed Ekramul Haque
About Divi's Lab
Divi's Laboratories Limited engages in the manufacture and sale of generic active pharmaceutical ingredients (APIs) and intermediates, and nutraceutical ingredients in India, North America, Asia, Europe, and internationally. It also undertakes custom... synthesis contract manufacturing services of APIs and intermediates; and supplies a range of carotenoids, such as beta carotene, astaxanthin, lycopene, and canthaxanthin, as well as other finished forms, including lutein, and vitamins to food, dietary supplement, and feed manufacturers industries. It also exports its products. The company was formerly known as Divi's Research Center and changed its name to Divi's Laboratories Limited in 1994. The company was incorporated in 1990 and is headquartered in Hyderabad, India. Read more
-
Incorporated
1990
-
Chairman
Ramesh BV Nimmagadda
-
Managing Director
Murali K Divi
-
Group
Divis Labs
-
Headquarters
Hyderabad, Telangana
-
Website
Looking for more details about Divi's Laboratories Ltd.’s IPO? Explore our IPO Details page.
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
Quarterly Updates
Annual Reports
FAQs for Divi's Lab
What is the current share price of Divi's Laboratories Ltd Today?
The share price of Divi's Laboratories Ltd is ₹6,710.50 (NSE) and ₹6,708.90 (BSE) as of 08-May-2026 IST. Divi's Laboratories Ltd has given a return of 26.81% in the last 3 years.
What is the current PB & PE ratio of Divi's Laboratories Ltd?
The P/E ratio of Divi's Laboratories Ltd is 71.84 times as on 08-May-2026, a 103 premium to its peers’ median range of 35.31 times.
The P/B ratio of Divi's Laboratories Ltd is 11.13 times as on 08-May-2026, a 349 premium to its peers’ median range of 2.48 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
69.83
|
10.22
|
|
2024
|
56.92
|
6.71
|
|
2023
|
41.05
|
5.87
|
|
2022
|
39.49
|
9.97
|
|
2021
|
48.56
|
10.37
|
What is the 52 Week High and Low of Divi's Laboratories Ltd?
The 52-week high and low of Divi's Laboratories Ltd are Rs 7,071.50 and Rs 5,636.50 as of 09-May-2026.
What is the market cap of Divi's Laboratories Ltd?
Divi's Laboratories Ltd has a market capitalisation of ₹ 1,78,100 Cr as on 08-May-2026. As per SEBI classification, it is a Large Cap company.
Should I invest in Divi's Laboratories Ltd?
Before investing in Divi's Laboratories Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.